Exploratory Study of Sensory Profile and Coping Strategies in Eating Disorders
Launched by CENTRE HOSPITALIER ESQUIROL · Jun 12, 2025
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how people with eating disorders—such as anorexia nervosa, bulimia nervosa, and episodes of overeating (called hyperphagia)—experience and respond to sensory information, like sights, sounds, or textures. The study also looks at how these individuals cope with their condition, while considering whether traits related to autism might affect these sensory experiences. The goal is to better understand the sensory profiles of people with different types of eating disorders.
If you are between 18 and 65 years old and have a confirmed diagnosis of one of these eating disorders, you may be eligible to take part, especially if you are currently receiving care at the Centre Hospitalier Esquirol. Participants will be asked to complete questionnaires that assess their eating disorder symptoms, body weight, anxiety levels, sensory experiences, and coping strategies. It’s important to note that people with certain other mental health conditions or sensory impairments won’t be able to join, and pregnant or nursing women are also excluded. Before joining, participants will provide informed consent, meaning they agree to take part after understanding what the study involves. This research has not started recruiting yet, but it aims to help improve support and treatment for people living with eating disorders by learning more about how they perceive and manage sensory information.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Gender and Age: Male or female, aged 18 to 65
- • Confirmed diagnosis of anorexia nervosa (F50.01; F50.02), boulimia nervosa (F50.2), hyperphagic episodes (F50.8) or restriction or avoidance of food intake (F50.8) according to DSM-5 criteria
- • Hospitalization or consultation for Eating Disorder at Centre Hospitalier Esquirol
- • Consent: Free, informed, and written consent, signed by the participant and/or their legal representative (for participants under protection measures) and the investigator (at the latest on the day of inclusion and before any research-related examination).
- Exclusion Criteria:
- • Psychiatric comorbidity (non-tobacco addiction, characterized depressive episode, bipolar disorder, obsessive-compulsive disorder, schizophrenia and related disorders, neurodevelopmental disorder)
- • History of Eating Disorder other than current disorder
- • Proven sensory or neurological disability
- • Inability to understand questionnaires and information related to the study
- • Persons under psychiatric care in accordance with articles L. 3212-1 and L. 3213-1
- • Pregnant, nursing or parturient women
- • Adults subject to legal protection or unable to express their consent to express their consent
- • Persons not affiliated to a social security scheme or not benefiting from one social security scheme
- • Persons deprived of their liberty by judicial or administrative decision
About Centre Hospitalier Esquirol
The Centre Hospitalier Esquirol is a leading healthcare institution dedicated to advancing mental health and psychiatric care through innovative research and clinical trials. With a commitment to improving patient outcomes, the center focuses on developing and evaluating new therapeutic approaches, fostering collaboration among multidisciplinary teams, and adhering to rigorous ethical standards. By leveraging its expertise and resources, the Centre Hospitalier Esquirol aims to contribute significantly to the understanding and treatment of mental health disorders, enhancing the quality of care provided to individuals in need.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Limoges, Nouvelle Aquitaine, France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported